(CORT) Corcept Therapeutics - Performance 208.2% in 12m
Compare CORT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
85.53%
#3 in Group
Rel. Strength
98.67%
#107 in Universe
Total Return 12m
208.23%
#4 in Group
Total Return 5y
466.43%
#7 in Group
P/E 57.7
88th Percentile in Group
P/E Forward 43.5
81th Percentile in Group
PEG 0.61
33th Percentile in Group
FCF Yield 2.75%
93th Percentile in Group
12m Total Return: CORT (208.2%) vs XLV (1.7%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: CORT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CORT
Total Return (including Dividends) | CORT | XLV | S&P 500 |
---|---|---|---|
1 Month | -37.07% | -3.79% | -0.87% |
3 Months | 7.41% | -3.99% | -7.58% |
12 Months | 208.23% | 1.72% | 11.88% |
5 Years | 466.43% | 55.40% | 110.33% |
Trend Score (consistency of price movement) | CORT | XLV | S&P 500 |
1 Month | -40.9% | -3.2% | 23% |
3 Months | 17.0% | -71.4% | -88.5% |
12 Months | 94.4% | -17.5% | 55.1% |
5 Years | 74.7% | 89.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #182 | -34.6% | -36.5% |
3 Month | #32 | 11.9% | 16.2% |
12 Month | #5 | 203% | 176% |
5 Years | #6 | 265% | 169% |
FAQs
Does CORT Corcept Therapeutics outperforms the market?
Yes,
over the last 12 months CORT made 208.23%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months CORT made 7.41%, while XLV made -3.99%.
Over the last 3 months CORT made 7.41%, while XLV made -3.99%.
Performance Comparison CORT vs Indeces and Sectors
CORT vs. Indices CORT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.20% | -36.2% | 48.6% | 196% |
US NASDAQ 100 | QQQ | -0.83% | -38.5% | 48.2% | 196% |
US Dow Jones Industrial 30 | DIA | 1.14% | -33.9% | 48.7% | 199% |
German DAX 40 | DAX | 1.43% | -38.4% | 29.1% | 184% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.16% | -34.3% | 51.6% | 202% |
Hongkong Hang Seng | HSI | 1.19% | -37.1% | 46.7% | 194% |
India NIFTY 50 | INDA | 3.04% | -41.1% | 48.4% | 205% |
Brasil Bovespa | EWZ | 1.0% | -41.7% | 44.9% | 214% |
CORT vs. Sectors CORT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.05% | -36.0% | 42.5% | 184% |
Consumer Discretionary | XLY | 0.12% | -37.0% | 46.1% | 195% |
Consumer Staples | XLP | 3.70% | -37.3% | 43.3% | 197% |
Energy | XLE | 4.68% | -23.2% | 54.4% | 219% |
Financial | XLF | 1.59% | -35.0% | 41.0% | 186% |
Health Care | XLV | 0.28% | -33.3% | 50.3% | 207% |
Industrial | XLI | -0.22% | -37.2% | 47.9% | 199% |
Materials | XLB | 0.81% | -34.6% | 56.1% | 212% |
Real Estate | XLRE | 1.72% | -35.8% | 49.5% | 190% |
Technology | XLK | -2.25% | -38.8% | 52.0% | 201% |
Utilities | XLU | 3.04% | -37.1% | 46.5% | 186% |
Aerospace & Defense | XAR | -0.75% | -43.5% | 35.1% | 182% |
Biotech | XBI | -1.10% | -39.4% | 61.3% | 210% |
Homebuilder | XHB | 0.89% | -34.8% | 63.5% | 215% |
Retail | XRT | 1.77% | -36.5% | 54.2% | 211% |